Plain-English translation of NCT06515821 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This clinical trial is evaluating four novel screening and diagnostic methods (called ONCO-VOC, ONCO-CRISP, ONCO-NMR, and ONCO-CTC) to detect colorectal cancer more effectively and conveniently than current standard tests. The study will compare how well these new methods work in people with colorectal cancer, people at high risk for the disease, and healthy individuals. By developing easier, non-invasive screening options, researchers hope to increase how many people actually get screened for colorectal cancer.
Colorectal cancer is one of the most common cancers, but current screening methods like colonoscopy have low participation rates, and standard blood tests in stool have limitations. This trial exists to create better, easier screening tools that more people will actually use—especially for younger people and those with risk factors like family history, obesity, or smoking.
You likely qualify if…
You likely don't qualify if…
Participants will complete a stool sample test (FOBT), undergo a colonoscopy performed by a doctor, and may have a tissue biopsy taken if needed. Depending on whether you have colorectal cancer, risk factors, or no risk factors, you'll be placed into one of four groups to help researchers understand how well the new screening methods work. The study involves one colonoscopy visit, though the exact timeline and number of additional tests may vary by group.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
Bulgaria
France
Germany